NanoViricides anti-Dengue drugs effective in new study

NanoViricides is reporting that its anti-Dengue fever drug candidates demonstrated efficacy in cell culture studies. The drug candidates are designed to mimic a "common natural host cell receptor by which the four different dengue virus serotypes bind to the body's host cells, thus causing disease. The virus is "fooled" into thinking it has attached to its target cell and instead enters a nanoviricide nanomicelle, it is believed. A nanoviricide would thus stop the spread of the viral infection to new uninfected cells." Release